We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
Cap. Flow
-$248M
Cap. Flow %
-0.63%
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 11.27%
2 Financials 10.78%
3 Industrials 9.91%
4 Healthcare 9.19%
5 Consumer Staples 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMAX icon
3076
RE/MAX Holdings
RMAX
$200M
$11K ﹤0.01%
286
-13
-4% -$467
SA
3077
Seabridge Gold
SA
$2.8B
$11K ﹤0.01%
789
SPYM
3078
State Street SPDR Portfolio S&P 500 ETF
SPYM
$158B
$11K ﹤0.01%
285
TDF
3079
Templeton Dragon Fund
TDF
$268M
$11K ﹤0.01%
587
TRST
3080
Trustco Bank Corp NY
TRST
$977M
$11K ﹤0.01%
244
UE icon
3081
Urban Edge Properties
UE
$2.94B
$11K ﹤0.01%
531
-239
-31% -$4.83K
WTI icon
3082
W&T Offshore
WTI
$545M
$11K ﹤0.01%
2,083
+227
+12% +$1.01K
SLCA
3083
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$11K ﹤0.01%
1,799
-441
-20% -$2.66K
NSTG
3084
DELISTED
NanoString Technologies, Inc.
NSTG
$11K ﹤0.01%
410
SCU
3085
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$11K ﹤0.01%
+500
New +$9.28K
AUD
3086
DELISTED
Audacy, Inc.
AUD
$11K ﹤0.01%
2,431
-1,516
-38% -$6.33K
ATRS
3087
DELISTED
Antares Pharma, Inc.
ATRS
$11K ﹤0.01%
2,498
BPFH
3088
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$11K ﹤0.01%
880
-24
-3% -$278
CZZ
3089
DELISTED
Cosan Limited
CZZ
$11K ﹤0.01%
+468
New +$8.31K
CZR
3090
DELISTED
Caesars Entertainment Corporation
CZR
$11K ﹤0.01%
824
OSG
3091
Octave Specialty Group
OSG
$252M
$10K ﹤0.01%
461
ARTNA icon
3092
Artesian Resources
ARTNA
$356M
$10K ﹤0.01%
274
-500
-65% -$18.5K
CAC icon
3093
Camden National
CAC
$924M
$10K ﹤0.01%
209
CAPR icon
3094
Capricor Therapeutics
CAPR
$1.14B
$10K ﹤0.01%
7,462
CWH icon
3095
Camping World
CWH
$363M
$10K ﹤0.01%
687
+129
+23% +$1.46K
DAL icon
3096
PUT
Delta Air Lines
DAL
$55.9B
$10K ﹤0.01%
+89
New +$4.99K
ECPG icon
3097
Encore Capital Group
ECPG
$1.93B
$10K ﹤0.01%
285
ETG
3098
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.74B
$10K ﹤0.01%
555
FITB
3099
PUT
Fifth Third Bancorp
FITB
$52B
$10K ﹤0.01%
+700
New +$20.5K
GBX icon
3100
The Greenbrier Companies
GBX
$1.61B
$10K ﹤0.01%
303
-236
-44% -$7.07K

Similar funds

US Bancorp's Q4 2019 Portfolio in Review

As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
  • US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
  • US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
  • US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
  • US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
  • US Bancorp opened 218 new positions and closed 148 in Q4 2019.
  • US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.

Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.